Normal view MARC view ISBD view

Cyclin-dependent kinase inhibitor 2A (p16) distinguishes well-differentiated liposarcoma from lipoma.

Gonzalez, Raul S

Cyclin-dependent kinase inhibitor 2A (p16) distinguishes well-differentiated liposarcoma from lipoma. [electronic resource] - Histopathology Jun 2013 - 1109-11 p. digital

Publication Type: Letter

ISSN: 1365-2559

Standard No.: 10.1111/his.12112 doi

Subjects--Topical Terms:
Biomarkers, Tumor--metabolism
Cyclin-Dependent Kinase Inhibitor p16--metabolism
Diagnosis, Differential
Female
Humans
Lipoma--diagnosis
Liposarcoma--diagnosis
Male
Middle Aged
Soft Tissue Neoplasms--diagnosis

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)